Vetter – About Us
More Content From Vetter – About Us
-
Vetter announces plans to expand its capacity in the U.S. and Germany
Leading globally operating CDMO outlines location and design of new manufacturing sites to meet increasing customer demands.News Releases Released on 06.06.2024
-
Vetter wins Best Managed Companies Award 2024
Jury of the renowned business award recognizes CDMO as Best in Class.News Releases Released on 05.28.2024
-
On the path to Net Zero: Vetter achieves new sustainability goals in 2023
CDMO presents third sustainability reportNews Releases Released on 05.08.2024
-
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Award
Trusted Industry Recognition Reinforces Vetter's Commitment to ExcellenceNews Releases Released on 03.28.2024
-
Vetter joins Science Based Targets Initiative (SBTi)
A leading global CDMO continues to drive its sustainability strategy forwardNews Releases Released on 03.01.2024
-
Vetter contributes to commercial launches of eight customer products in 2023
Portfolio of early- and late-stage clinical services advances product development for injectablesNews Releases Released on 03.01.2024
-
Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)
Globally operating CDMO committed to strengthening Germany as a research and production locationNews Releases Released on 03.01.2024
-
Vetter looks ahead to further expansions to meet supply chain demand
Ongoing investments in the supply chain for complex injectable medications.News Releases Released on 11.03.2023
-
Unlock the Full Potential of Your Injectable Product
We're Vetter - a leading global CDMO partner for your injectable product program.Literature / Brochures Released on 11.03.2023
-
Vetter's Sustainability Report 2022
This report is aligned with the German Sustainability Code (GSC) guidelines.Literature / Brochures Released on 11.03.2023
-
Vetter at a Glance - Your Strategic CDMO Partner
We’re a global expert in aseptic filling and packaging of injectable drug products.Literature / Brochures Released on 11.03.2023
-
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development.News Releases Released on 10.16.2023
-
Vetter earns Frost & Sullivan’s Customer Value Award for the third time
Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services.News Releases Released on 10.16.2023
-
Gold status for Vetter: Named Best Managed Company for the fourth time
CDMO honored as an exceptionally managed companyNews Releases Released on 10.16.2023
-
High demand: Vetter expands production capacities and services offered at its Austrian site
Pharma service provider further expands offerings for clinical development and manufacturing.News Releases Released on 10.16.2023
